增殖性糖尿病性视网膜病变玻璃体手术中曲安奈德应用的临床疗效分析(2)
 |
| 第1页 |
参见附件(3246KB，3页)。
[2] Davis MD. Vitreous contraction in proliferative diabetic retinopathy[J].Arch Ophtalmol, 1965,74:741-751.
[3] Takahashi M, Trempe CL, Maguire K, et al. Vitreoretinal relationship in diabetic retinapathy Labiomicroscopic evaluation[J]. Arch Ophthalmol,1981,99:241-245.
[4] Glaser BM. Surgery of prolifarative vetrcoretionpathy[M].In Ryan SJ, ed Retina 2nd ed St. Louis CV Mosby,1994:2265-2280.
[5] Johnson RN, Glss JD. Idiopathic macular hole: observations, stages of formation, and implications for surgical intervention[J].Ophthalmology,1988,95:917-924.
[6] 杨培增.临床葡萄膜炎[M].北京:人民卫生出版社,2004:61-62.
[7] Mc Cuen BW, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide [J]. Am J Ophthalmol,1981,91(6):785-788.
[8] Schole GN, Brien WJ, Abrams GW, et al. Clearance of triamcinoline from vitreous [J]. Arth Ophthalmol,1985,103:1567-1569.
[9] Schindler RH, Chandler D, Thresher R, et al. The clearance of intravitreal trimcinlone acetonidem [J]. Am J Ophthalmol,1982,93:415-417.
[10] Gopal L, Bhende M, Sharma T. Vitrectomy for accidental intraocular steroid injection [J]. Retina,1995,15:295-299.
[11] Kivilcim M, Pegman GA, El-Dessouky ES, et al. Retinal toxicity of triamcinolone acteonide in silicone-filled eyes[J]. Ophthalmic Surg Lasers,2000,31:474-478.
[12] Gillies M, Simpson JM, Billson FA, et al.Safety of an intravitreal injection of triamcinolone. Results from a randomized clinical trail [J]. Arch Ophthalmol,2004,22:336-340.
[13] Peyman GA, Cheema R, Conway MD, et al. Triamicinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid druing pars vitrecyomy [J]. Retina,2000,20:554-555.
[14] Joans JB, Hayler JK, Panda-Joans S. Intravitreal injection of Crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy [J]. Br J Ophthalmol,2000,84(9):1064-1067.
(收稿日期：2011-03-07)
您现在查看是摘要介绍页，详见PDF附件(3246KB，3页)。